10th Annual National Head and Neck oncology meeting
Friday 15th September saw the 10th annual National Head and Neck Oncology meeting take place in York, chaired by our very own Trustee Dr Mehmet Sen. The focus of this annual meeting is on recent advances, impact on routine NHS practitioners and changes affecting Head and Neck Oncology. This is complimentary to other UK Head and Neck meetings and an opportunity for knowledge sharing amongst multidisciplinary team members to improve patient care within NHS practice.
Dr Mehmet Sen:
“In 2023 we observed many challenges within healthcare including increasing numbers of patients awaiting treatment, underfunding of health care needs, pay disputes and strikes, disbanding of NCRI and uncertainties for head and neck research in the future. This conference however demonstrated the strength and spirit of collaboration within the UK Head and Neck Cancer community, as evidenced by an excellent turnout and colleagues from most national centres. Areas of variance were identified and opportunities to align using agreed upon evidence-based approaches were shared. New seminal trial data was shared for the first time and opportunities for new trials discussed.”
Dr Sen also announced the news that this annual event will become a key flagship event for Oracle Cancer Trust. Oracle will ensure the event continues with high levels of governance and sustainability going forward, providing opportunity for information sharing and collaboration within this healthcare community.
Tamara Kahn, CEO Oracle Cancer Trust:
“This meeting really demonstrates the importance of information sharing and discussion amongst oncology and multidisciplinary colleagues from across the UK. Topics such as Systemic Therapies and Immunotherapies, Radiotherapy case studies, Sinonasal surgery and options were discussed amongst many others. This will be a core Oracle educational event in 2024 and we look forward to working with the Steering Committee, building on their success to date.”
To learn more and keep up to date on our latest news please sign up to our newsletter today.

2 Minutes to Save Your Life: Oracle Launches HeadNeckCheck Campaign for Make Sense Week
This Make Sense Week (15-20 September), the European-wide head and neck cancer awareness initiative, Oracle Head & Neck Cancer UK, is championing both prevention and early detection – recognising that stopping cancer before it starts is just as vital as catching it early. Two Ways to Fight Cancer This Week Prevention Today: Head and neck…

Leadership update
After four successful years as CEO, Tamara Kahn has transformed Oracle into a respected national voice for head and neck cancer patients. She established a national presence, created a four-pillar RACE strategy (Research, Awareness, Collaboration and Patient/Community Engagement) and built strong policy influence. With these foundations now firmly in place, Tamara will transition from her…

Finding Light in Adversity: Seven inspiring stories through head and neck cancer
A new collection of patient stories from Oracle Head and Neck Cancer UK reveals how individuals facing head and neck cancer have discovered unexpected sources of strength, purpose and even joy during their treatment and recovery. The seven contributors share remarkably similar themes despite their unique journeys. Almost all emphasise the power of maintaining a…

NHS to fast-track patients with head and neck cancer into cancer vaccine trial
Patients with advanced head and neck cancers in England will be fast-tracked into a trial of a new cancer vaccine, as the NHS expands its world-leading trial ‘match-making’ service. The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus proteins. More than 100 patients with advanced head…

World Head and Neck Cancer Awareness Day 2025: The HPV Vaccine Could Save Your Life
27th July 2025 This World Head and Neck Cancer Awareness Day, Oracle Head and Neck Cancer UK has a simple but urgent message: HPV vaccination saves lives. With HPV-related head and neck cancers having doubled in the past 20 years, the charity is using today to remind the public that these devastating cancers are preventable…

Data from the National Disease Registration Service on HPV associated and HPV independent oropharyngeal squamous cell carcinoma
The Get Data Out Programme from the National Disease Registration Service (NDRS), part of NHS England, has published statistics on incidence, routes to diagnosis and treatment for patients diagnosed with oropharyngeal cancer in England by human papillomavirus (HPV) status. To our knowledge this is the first time data on oropharyngeal cancer by HPV status has…

Join Us for an Evening of Research, Impact, and Conversation
Research & Impact EveningDate: Monday 28th April 2025Time: 6:00 PM – 8:30 PMVenue: Skyline, Tower Suites, 100 Minories, London EC3N 1JY A Celebration of Research Join us for a meaningful and action-focused evening where we’ll be diving into some of the big conversations around head and neck cancer – especially those linked to HPV (human…

What the Rare Cancers Bill Means for Head & Neck Cancer
14 March marked a crucial moment for research into rare cancers, as the Rare Cancers Bill took another significant step toward becoming law! Dr. Scott Arthur, a Labour MP, introduced this legislation in Parliament to drive much-needed research into cancers affecting fewer than 1 in 2000 people in the UK – including many types of…

Theatre Meets Healthcare: Breaking Barriers in Cancer Conversations
In Leicester, theatre is transforming how Black communities talk about cancer. Oracle Head & Neck Cancer UK, alongside Theatre Sans Frontières, is using interactive Forum Theatre to tackle stigma, improve healthcare conversations, and break down cultural barriers. Actors bring real-life cancer diagnosis experiences to the stage – but the audience isn’t just watching. They step in, suggest changes, and…

Jamie Theakston Announces He is Cancer-Free After Laryngeal Cancer Treatment
Heart Breakfast’s much-loved presenter, Jamie Theakston, has shared the incredible news that he is now cancer free! After completing treatment for stage one laryngeal cancer – cancer of the voice box (larynx), Jamie made his highly anticipated return to the airwaves today, reuniting with listeners and co-hosts alike. Diagnosed in September 2024, Jamie initially thought…